Ellyn Needel Manager, Federal Affairs Ellyn Needel is the Manager of Federal Affairs for PCMA where she monitors federal activities for the organization and our members. Previously, Ellyn was a Health Policy Associate at Venn Strategies where she tracked and
Brianna Jones Senior Manager, Research Brianna Jones is a Senior Manager, Research. Prior to joining PCMA, Ms. Jones worked as a Policy Analyst at the Patients for Affordable Drugs. Ms. Jones graduated with a B.A. in Political Science and Journalism
Debjani Mukherjee Senior Director, Regulatory Affairs Debjani Mukherjee is the Senior Director for Regulatory Affairs and joins the team with significant experiences in science & quality policy, quality measure and guideline development as well as regulatory affairs. She has worked
Brianna Jones is the Manager, Research at PCMA. Prior to joining the organization, Ms. Jones worked as a Policy Analyst at the Patients for Affordable Drugs. She graduated with a B.A. in Political Science and Journalism from the University of Central
Debjani Mukherjee is the Senior Director, Regulatory Affairs at PCMA. She joins the team with significant experiences in science & quality policy, quality measure and guideline development as well as regulatory affairs. She has worked with the Planned Parenthood Federation, NQF,
Johnny Garcia, PharmD Senior Director, Policy Johnny Garcia, PharmD is Senior Director, Policy for PCMA. He has more than two decades of pharmaceutical experience, having worked in many areas of the industry, including pharmacy retail, mail order pharmacy, specialty pharmacy,
Sign Up Name(Required) First Name Last Name Email(Required) Phone(Required) Consent Sign up for SMS UpdatesBy providing your phone number, you are consenting to receive calls and SMS/MMS messages, including autodialed and automated calls and texts, to that number from PCMA.
The so-called “delinking” policy made news last week with the introduction of H.R. 6283. Among several glaring problems — including a rejection of free market performance-based incentives that lower drug costs for consumers — if enacted, “delinking” would hand a
Encouraging Signs that the Insulin Affordability Battle is Improving This week, as congressional hearings focus on access to affordable insulins, it should be recognized that a multitude of market forces are working to reduce the cost of insulin products for
©2024 PCMA. All Rights Reserved.
